From muscle wasting to sarcopenia and myopenia: update 2012 Stephan von HaehlingJohn E. MorleyStefan D. Anker Editorial 17 November 2012 Pages: 213 - 217
Research on cachexia, sarcopenia and skeletal muscle in cardiology Andrew J. S. Coats Review 16 November 2012 Pages: 219 - 223
Consilience in sarcopenia of cirrhosis Srinivasan Dasarathy Review Open access 31 May 2012 Pages: 225 - 237
Anorexia/cachexia of chronic diseases: a role for the TGF-β family cytokine MIC-1/GDF15 Vicky W. W. TsaiYasmin HusainiSamuel N. Breit Review 31 August 2012 Pages: 239 - 243
Predicting survival in cancer patients: the role of cachexia and hormonal, nutritional and inflammatory markers Anne E. UtechEiriny M. TadrosJose M. Garcia Original Article 31 May 2012 Pages: 245 - 251
Cancer cachexia and anabolic interventions: a case report Edgar L. DillonGurjot BasraMelinda Sheffield-Moore Original Article Open access 15 May 2012 Pages: 253 - 263
Cancer cachexia is associated with a decrease in skeletal muscle mitochondrial oxidative capacities without alteration of ATP production efficiency Cloé M. JulienneJean-François DumasStephane Servais Original Article Open access 31 May 2012 Pages: 265 - 275
Ursodeoxycholic acid and its emerging role in attenuation of tumor growth in gastrointestinal malignancies Shailendra Kapoor Letter to the Editor 13 November 2012 Pages: 277 - 278
Bile acids for cachexia therapy Anika TschirnerJochen Springer Letter to the Editor 13 November 2012 Pages: 279 - 279
Abstracts of the Cancer Cachexia Conference, Boston, USA, 21–23 September 2012 Abstracts 08 November 2012 Pages: 281 - 301